Cultures of a stable L-phase variant of Streptococcus faecium F24 produced and retained peptidoglycan precursors intracellularly over the entire growth cycle in a chemically defined medium. The identity of the most abundant precursor, UDP N-acetylmuramyl-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D-alanine (UDPMurNAc-pentapeptide), was confirmed by demonstrating in vitro the presence of enzymes required for the cytoplasmic stage of peptidoglycan biosynthesis. The initial membrane-bound reaction in peptidoglycan biosynthesis involving phospho-MurNAc-pentapeptide translocase and undecaprenyl-phosphate membrane carrier was catalyzed by protoplast membrane preparations but not by L-phase membrane preparations. However, both protoplast and L-phase membranes incorporated radioactivity from dTDP-L-['4C]rhamnose, the presumed precursor to a non-peptidoglycan cell surface component, into high-molecular-weight material. dTDP-L-rhamnose did not accumulate in growing cultures but was synthesized from D-glucose-l-phosphate and dTTP by cell-free extracts of the streptococcus and L-phase variant. Neither rhamnose-nor muramic acid-containing compounds were detected in culture fluids. It is suggested that continued inhibition of cell wall biosynthesis in this stable L-phase variant is the result of a defect expressed at the membrane stage of peptidoglycan biosynthesis specifically involving the translocation step.
Muralytic enzymes (such as lysozyme and bacterial autolysins) and various antibiotics (including the penicillins, cycloserine, bacitracin, and phosphonomycin) act via several different mechanisms to interrupt either the structural integrity of preforned bacterial cell walls or the sequence of biochemical reactions which ultimately leads to the synthesis of complete walls (7) . Bacteria treated with one of these agents in an appropriate environment may exhibit dramatic phenotypic changes as a result of cell wall damage (12) . Phenotypic variants produced by such treatment can retain physiological and metabolic activity and presumably contain a complete complement of parental cell wall biosynthetic machinery. Indeed, after the wall-active agent is neutralized or eliminated, certain wall-defective variants can immediately resume the assembly of intact cell walls and then quickly regain the morphology of parent organisms (2, 5, 18) . The tendency to revert to the parental phenotype is usually greatest immediately after exposure to the inducing agent and decreases with continued cultivation. Upon extended subculture in a selective environment, a population may emerge composed of "stable" variants that have apparently lost the ability to reassemble cell walls and cannot revert to parental morphology. To describe the stable L-phase phenotype in biochemical terms, marker compounds were used to assess cell wall biosynthesis in a nonreverting L-phase variant. Specifically, rhamnose and muramic acid were selected to determine the stage at which cell wall biosynthesis is inhibited in a lysozyme-produced, stable L-phase variant of Streptococcus faecium F24.
MATERIALS AND METHODS
Organisms and growth conditions. S. faecium strain F24 (ATCC 19634 ) and a nonreverting L-phase variant (ATCC 19635) , which was derived from a lysozyme-converted protoplast inoculum of S. faecium F24 (17) , were propagated at 37°C in a 43-component, chemically defined medium (SM) without antibiotics (11) . The variant exhibited typical L-form morphology when grown on solid media; liquid SM was used to aid the task of analyzing spent media for products of Lphase metabolism. Growth was monitored with a Klett-Summerson colorimeter (green filter, 540 nm). King and Gooder (17) was used to prepare fresh protoplasts in 8% (wt/vol) polyethylene glycol. Protoplasts produced by this method are free of cell walls as determined previously (10, 17) by (i) release of the Lancefield streptococcal group D antigen located between the cell wall and plasma membrane, (ii) inability of phage P13 to attach to protoplasts, (iii) loss of more than 90% of total cellular rhamnose, and (iv) absence of cell wall fragments when examined by transmission electron microscopy.
Characterization of accumulated precursors. Total bound N-acetylhexosamine (HexNAc) in cultures was estimated from 40-ml samples which were removed at various times from cultures growing in SM. Washed cells were suspended in distilled water and were subjected to three cycles of flash freezing and thawing. The resulting suspension was centrifuged at 17,300 x g for 30 min, the pellet was extracted with 5% (wt/vol) cold trichloroacetic acid, and the two supernatants were combined. Trichloroacetic acid was removed with ether, and the aqueous portion was analyzed for total HexNAc or concentrated by lyophilization for nucleotide characterization. For preparation of UDP N-acetylmuramyl-L-alanyl-D-glutamyl-L-lysine (UDP-MurNAc-tripeptide), streptococci were grown in medium containing the L isomer of alanine (200 gg/ml) rather than the usual isomeric mixture (11) 34 ,000 x g for 20 min. The enzyme used in the alanine dipeptide adding system (UDP-MurNAc-tripeptide:D-alanyl-D-alanine ligase; EC 6.3.2.10) was prepared from cells which were broken in 10 mM phosphate buffer (pH 6.8) with a Branson Sonifier-Cell Disruptor (Heat Systems-Ultrasonics, Inc.) with microtip at a 50-W output. These preparations were cleared of cell debris by centrifugation and were partially purified by protamine and ammonium sulfate fractionation as described by Neuhaus and Struve (24) . Crude enzyme preparations for the synthesis of dTDP-L-rhamnose were prepared in 50 mM Tris-hydrochloride (pH 8.0) containing 10 mM MgCl2 and 1 mM ethylenediaminetetraacetic acid by similar sonic treatment and centrifugation.
Membrane-associated enzyme preparations for the phospho-MurNAc-pentapeptide translocase (EC 2.7.8.13) system were obtained from whole-cell suspensions of the L-phase variant and protoplasts by a combination of osmotic lysis in 50 mM Tris-hydrochloride (pH 7.8) containing 1.0 M KCl and 20-s sonic bursts. Membrane fragments were collected by centrifugation at 39,100 x g for 25 min (40C) after each of the three resuspensions and sonic treatments. The enzyme system was partially purified by the method of Struve et al. (33) by centrifugation four times between 1,085 x g (45 min) and 39,100 x g (25 min). Endogenous bound precursor was removed from these preparations by the UMP-exchange reaction described by Hammes and Neuhaus (13) . Membrane preparations for the rhamnosyl translocase reaction were obtained essentially as described by Panos and (26) was followed in analyzing hot 5% trichloroacetic acid extracts of lyophilized samples of washed whole-cell preparations or membrane fragments from the rhamnosyl translocase system. After removal of trichloroacetic acid with ether, samples were subjected to chromatography on a Sephadex G-25 column (1.6 by 90 cm) using 0.01 N acetic acid at a flow rate of approximately 25 ml/h. Fractions (2.0 ml) were collected, and rhamnose was quantitated by the cysteine-hot sulfuric acid method of Dische and Shettles (3). Portions of fractions were paper chromatographed in solvent system A. Chromatography. Paper chromatography was descending at 25°C on washed Whatman no. 1 or 3MM paper in the following solvent systems (by volume): (A) 1-butanol-pyridine-water (45:25:50), (B) isobutyric acid-1.0 M ammonium hydroxide (5:3), (C) ethanol-1.0 M ammonium acetate, pH 7.5 (7:3), (D) pyridine-water (4:1), and (E) 1-butanol-acetic acid-water (4:1:1). Nucleotides were located by absorption of UV light and amino acids and amino sugars were located after chromatograms were sprayed with a solution of 0.3% ninhydrin in ethanol (Sigma) and heated (105°C, 3 min). Carbohydrates were detected after heating (105°C, 2 min) chromatograms which had been sprayed with a 0.2% solution of acidified aniline diphenylamine (Sigma).
Thin-layer chromatography was ascending at 250C on plates of 0.25-mm-thick Silica Gel G (Brinkman Instruments, Inc.) impregnated with 50 ml of 0.1 N boric acid per 25 g of silica. The following solvent systems were used (by volume): (A) 1-propanolammonium hydroxide-water (6:2:1), (B) acetonewater (9:1), and (C) methyl ethyl ketone-acetic acidmethanol (3:1:1). Detection of carbohydrates and amino acids was as on paper, and, in addition, a spray consisting of 95% ethanol-concentrated sulfuric acid-anisaldehyde (18:1:1) was used for sugar detection. Sprayed plates were heated at 90°C for 10 min to detect as little as 0.05 jig of sugar.
Column chromatographies were prepared and run at 25°C according to technical information supplied by the respective manufacturers. Gel filtration was on Sephadex G-25 (Pharmacia Fine Chemicals AB). Dowex 1-X4 (Bio-Rad; 50 to 100 mesh) was used for nucleotide separations (formate form) and Bio-Rad AG 50 W-X8 (200 to 400 mesh) was used as supplied in the hydrogen form for the alanine ligase assay or converted to the sodium form for the alanine dipeptide adding assay and optical configuration determinations. Column dimensions, buffer systems, flow rates and fraction volumes are indicated in appropriate sections along with specific applications.
Amino acids and amino sugars were quantitated with a Beckman automated amino acid analyzer after acid hydrolysis of samples. Samples of nucleotidebound precursors were hydrolyzed under partial vacuum with 2.0 ml of 5 N HCI for 4 h for amino sugars and 18 h for amino acids at 105°C.
Other procedures. The HexNAc content of nucleotide-bound precursors was determined by the method of Reissig et al. (27) after samples were hydrolyzed for 15 min at 100°C in sealed vials containing 0.5 to 0.01 N HCI. Total protein added to enzyme assays was determined by the Lowry procedure (20) .
Products separated by ion-exchange chromatography from alanine ligase reaction mixtures were subjected to paper chromatography using solvent system B, D, or E with alanine, alanine dipeptide, and alanine tripeptide standards. The optical configuration of alanine in reaction products of alanine ligase assays was determined after treatment with D-amino-acid oxidase (EC 1.4.3.3; Sigma) or L-alanine aminotransferase (EC 2.6.1.2; Sigma) by the procedure of Lynch and Neuhaus (21) .
Radioactive samples were counted in either a toluene-based (for samples on paper) or toluene-Triton X-100 (for liquid samples) scintillation fluid using a Packard Tri-Carb liquid scintillation spectrometer.
Chemicals Characterization of peptidoglycan precursors. Cold trichloroacetic acid extracts of freeze-thaw cell preparations were fractionated by ion-exchange chromatography as shown in Fig. 2 . Elution from the column resulted in precursor-containing peaks which absorbed at 260 nm and were positive for bound HexNAc. The elution pattern of extracts from the L-phase variant ( Fig. 2A) (Fig. 2B ). This peak corresponds to peak IV in the elution protile of the variant. Extracts of cycloserinetreated streptococci (Fig. 2C) were eluted from the column in a major precursor-containing peak, peak I, just ahead of the peak II position ( Fig. 2A) , and two minor peaks. Identification and quantitative analysis of the components were done on material from appropriately pooled fractions which had been desalted and concentrated by charcoal adsorption. The UV absorption spectra at pH 7.0 of all samples examined were similar to uridine nucleotides: absorption maximums and minimums were 262 and 230 nm, respectively, whereas 250/260-and 280/260-nm absorbance ratios were 0.72 to 0.74 and 0.35 to 0.39, respectively. Nucleotides were hydrolyzed and subjected to quantitative analysis (Table 1) . Material from peak I, isolated from cycloserine-treated streptococci, appears to be UDP-MurNAc-tripeptide, and peak II material, from the variant, is apparently UDP-MurNAc-pentapeptide. Peaks IlI and IV from both organisms appear to contain UDP-N-acetylglucosamine and UDP-MurNAc as major components, respectively, but probably represent mixtures of these two precursors plus small amounts of UDP-MurNAc-L-alanine. The pentapeptide-containing precursor (peak II) accounts for approximately 62% of the total bound HexNAc recovered from the L-phase variant (Fig. 2) , whereas 29 and 9% of the total are in peaks III and IV, respectively. UDP-MurNActripeptide (peak I) accounts for 76% of the total bound HexNAc from cycloserine-treated streptococci and only 18 and 6%, respectively, are in peaks III and IV. Cytoplasmic stage of peptidoglycan synthesis. The identity of the major peptidoglycan precursor accumulated by the L-phase variant was confirmed enzymatically, as shown in Table  2 , by assaying L-alamine racemase, D-alanine:Dalanine ligase, and UDP-MurNAc-tripeptide:Dalanyl-D-alanine ligase. Functional abilities to convert L-alanine to the D isomer and to synthesize alanine dipeptide from D-alanine were apparent in extracts of the L-phase variant and streptococcus. Results of paper chromatography in solvent systems B, D, and E before and after acid hydrolysis of the reaction product were consistent with the synthesis of alanine dipeptide; results of treating dipeptide hydrolysates with D-amino acid oxidase or L-alanine aminotransferase indicated that the synthetic product ofthe combined racemase-ligase reaction system was composed of D isomers of alanine (data not shown). Extracts of both organisms also formed the completed cytoplasmic precursor to peptidoglycan from alanine dipeptide and UDPMurNAc-tripeptide. The product of this reaction, UDP-MurNAc-pentapeptide, had an RUMP of 0.57 (versus an RUMP of 0.38 for unreacted UDP-MurNAc-tripeptide) on paper chromato- (Table 3) . Although the total membrane uptake (acid-precipitable radioactivity) was greater in the protoplast system than in the L-phase variant system, about 75% of hot trichloroacetic acid-extracted radioactivity from both membrane systems was eluted in the void volume as a presumptive intermediate to a nonpeptidoglycan cell surface component with a molecular weight exceeding that of monomeric rhamnose (or dTDP-rhamnose). In addition, this material did not migrate on thin-layer plates with solvent system B, but rhamnose was detected in an acid hydrolysate analyzed with the same system. DISCUSSION Microorganisms are capable of remarkably varied responses when they are placed in a new environment. For example, when lysozyme-induced protoplasts of S. faecium F24 are incubated on medium solidified with gelatin, they resynthesize cell walls and readily revert to apparently intact streptococci (18) . On soft agar, c Acid-precipitable radioactivity in membrane fragments as percentage of the total radioactivity added to the rhamnosyl translocase system. d Radioactivity which was extracted from membrane fragments (rhamnosyl translocase system) with hot trichloroacetic acid and which was eluted in the void volume of Sephadex G-25 chromatography; expressed as percent of total uptake in the respective membrane system. 'ND, Not determined.
however, only sporadic revertants are observed, and protoplasts are quantitatively converted to L-phase variants. Shockman and co-workers have recently reported that growing protoplasts (autoplasts) of S. faecalis ATCC 9790 synthesize and excrete soluble peptidoglycan fragments (29) and glycan chains (31) . These freshly prepared autoplasts synthesize soluble peptidoglycan fragments in amounts equivalent to the total peptidoglycan synthesized by streptococci for insertion into intact cell walls (29) . In addition, reverting protoplasts of Bacillus licheniformis produce peptidoglycan and teichoic acid polymers (5 faecium F24 rather than extruded into the growth medium or not synthesized at all. The presumptive lesion is in the membrane stage of peptidoglycan biosynthesis at the reaction catalyzed by phospho-MurNAc-pentapeptide translocase. This conclusion is based on the identity of the predominant precursor accumulated, the lack of demonstrable translocase activity in L-phase membrane preparations, and the absence of muramic acid-containing compounds in culture fluids. The significance of small amounts of incomplete precursor is unknown, but it may reflect the kinetics of the UDP-MurNAc:L-alanine ligase reaction, which is the rate-limiting reaction in the cytoplasmic sequence of peptidoglycan synthesis (16) . Alternatives to a defect in the translocase itself include a defective membrane carrier, perhaps brought about by structural rearrangements within the L-phase membrane. Such membrane rearrangements could inhibit carrier function or prevent regeneration (dephosphorylation) of undecaprenyl-pyrophosphate, but this is unlikely (1, 34 (22) . A lesion in peptidoglycan synthetase could lead to undecaprenyl diphosphate-disaccharide accumulation in the membrane, thus limiting available undecaprenyl phosphate and resulting in the observed lack of translocase activity in the variant despite preincubation with UMP. It is not known whether this variant responds to inhibition of cell wall biosynthesis by secreting lipids into the medium, which occurs in several streptococcal species when they are treated with inhibitors of peptidoglycan biosynthesis (14 (13, 22) .
Lesions affecting wall biosynthesis in L-phase variants have been characterized as defects in peptidoglycan biosynthesis and not in the synthesis of accessory wall polymers (26, 34) ; thus, the production of peptidoglycan in vivo may dominate the biosynthetic interface of peptidoglycan and accessory polymer incorporation into cell walls. Extracts of the L-phase variant analyzed here retain the ability to synthesize dTDP-L-rhamnose, presumed cytoplasmic precursor to a non-peptidoglycan cell surface polymer, but rhamnose-containing compounds are not produced in stoichiometric amounts by growing cultures of the variant. The lack of accumulation of rhamnosyl nucleotide in either the L-phase variant or cycloserine-treated streptococci may reflect the efficient regulation of dTDP-L-rhamnose production in vivo. A previous report has shown that dTDP-D-glucose pyrophosphorylase is subject to feedback inhibition by dTDP-Lrhamnose (23) . Because rhamnose can be incorporated in vitro from precursor into a high-molecular-weight membrane-associated component in the absence of a preformed cell wall, the membrane lesion affecting peptidoglycan synthesis does not prohibit membrane uptake of rhamnose. However, only low levels of rhamnose were detected in whole L-phase organisms. These observations may indicate the existence of a mechanism(s) for the regulation of the synthesis of precursors to secondary cell wall polymers that is independent of the synthesis of peptidoglycan precursors. Perhaps dTDP-Lrhamnose is another cell wall precursor which shares the undecaprenyl-phosphate carrier (35). The data presented here imply that the lipid carrier, if involved in rhamnose assimilation, was intact and operational in this stable L-phase variant.
The synthesis of peptidoglycan is a strongly conserved trait, because several wall-defective variants continue to produce precursors even on extended subculture in osmotically balanced media when intact peptidoglycan apparently ceases to be a survival prerequisite. L-phase variants with defects at the postmembrane stage of peptidoglycan biosynthesis have not been described; perhaps reactions which occur outside the osmotic barrier of cell wall-damaged cells are at a selective disadvantage in competitive microbial populations (34) or are masked by the preeminence of autolysins (2). We do not understand the selective pressures which act on these organisms, but the outgrowth of stable L-phase variants in established cultures may be the expression of genotypic changes. For example, Leder-J. BACTERIOL. (19) . These variants regained parental morphology when the amino acid was again supplied in the growth medium. In addition, Wyrick et al. reported that the stable L-phase phenotype could be transferred from lysozyme-derived variants of B. subtilis to intact bacilli by genetic transformation (36) . The L-phase transformants (about 10% of the recombinants) retained nutritional markers and did not revert to bacilli on hard agar or on medium containing 25% gelatin.
We now have a basis for understanding the molecular nature of continued cell wall inhibition in stable L-phase variants: microorganisms can permanently lose the ability to synthesize cell walls as the result of specific lesions which affect any of the several reactions unique to the cell wall biosynthetic sequence. Future genetic and biochemical analyses of stable L-phase variants should provide a direct approach to study the control of cell wall biosynthesis.
